Expression of interferon-inducible T cell α chemoattractant (CXCL11) in the salivary glands of patients with Sjogren's syndrome

被引:32
作者
Ogawa, N [1 ]
Kawanami, T [1 ]
Shimoyama, K [1 ]
Ping, L [1 ]
Sugai, S [1 ]
机构
[1] Kanazawa Med Univ, Div Hematol & Immunol, Dept Internal Med, Uchinada, Ishikawa 9200293, Japan
关键词
human; salivary epithelial cells; IFN-gamma; IP-10; Mig; I-TAC; RT-PCR; ELISA; immunohistochemistry;
D O I
10.1016/j.clim.2004.03.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the possible involvement of interferon-inducible T cell a chemoattractant (I-TAC or CXCL11) in the salivary gland lesions of Sjogren's syndrome (SS), I-TAC mRNA expression was assayed in cultured salivary epithelial cells by reverse transcriptase-polymerase chain reaction (RT-PCR). This transcript was not expressed by SS salivary epithelial cells in the absence of IFNgamma but was expressed after cells were stimulated with IFNgamma. We found that IFNgamma was the only cytokine that induced I-TAC mRNA expression. I-TAC proteins were shown by ELISA to be secreted into the culture supernatants of SS salivary epithelial cells following IFNgamma stimulation. Moreover, immunohistochemical assays of minor salivary glands (MSG) showed that I-TAC was predominantly located in the ductal epithelium adjacent to lymphoid infiltrates in the SS salivary gland, indicating that ductal epithelial cells produce I-TAC proteins in response to stimulation with IFNgamma secreted by lymphocytes that infiltrate into SS salivary glands. In contrast, I-TAC proteins were virtually absent from normal salivary glands. These findings suggest that I-TAC is involved in the development of salivary gland lesions observed in SS. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 17 条
  • [1] Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO
  • [2] 2-9
  • [3] Blocking chemokine receptors
    Baggiolini, M
    Moser, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) : 1189 - 1191
  • [4] Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome
    Belperio, JA
    Keane, MP
    Burdick, MD
    Lynch, JP
    Xue, YY
    Li, KW
    Ross, DJ
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 1037 - 1049
  • [5] Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
    Cole, KE
    Strick, CA
    Paradis, TJ
    Ogborne, KT
    Loetscher, M
    Gladue, RP
    Lin, W
    Boyd, JG
    Moser, B
    Wood, DE
    Sahagan, BG
    Neote, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) : 2009 - 2021
  • [6] Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3:: Differential binding to receptor states
    Cox, MA
    Jenh, CH
    Gonsiorek, W
    Fine, J
    Narula, SK
    Zavodny, PJ
    Hipkin, RW
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (04) : 707 - 715
  • [7] Cuello C, 1998, BRIT J RHEUMATOL, V37, P779
  • [8] Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells
    Dwinell, MB
    Lügering, N
    Eckmann, L
    Kagnoff, MF
    [J]. GASTROENTEROLOGY, 2001, 120 (01) : 49 - 59
  • [9] The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions
    Flier, J
    Boorsma, DM
    Bruynzeel, DP
    van Beek, PJ
    Stoof, TJ
    Scheper, RJ
    Willemze, R
    Tensen, CP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (04) : 574 - 578
  • [10] Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome
    Kong, LP
    Ogawa, N
    Nakabayashi, T
    Liu, GT
    DSouza, E
    McGuff, HS
    Guerrero, D
    Talal, N
    Dang, H
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (01): : 87 - 97